Html code here! Replace this with any non empty text and that's it.
SGLT2 Inhibitors and Cardiovascular and Renal Outcomes
During a poster session at the American Society of Nephrology Kidney Week 2022, Thomas Mavrakanas, MD, MSc, and colleagues reported results of a systematic...
Serum Zinc Levels in Patients with Diabetes
Results of recent studies have suggested that patients with diabetes may have low zinc intake associated with unbalanced diet and changes in lifestyle. Mitsunobu...
SGLT-2 Inhibition in Kidney Transplant Recipients With Diabetes
Previous studies have shown that the use of sodium glucose linked transporter inhibitors (SGLT-2i) in nontransplant patients with diabetes and chronic kidney disease (CKD)...
Patient and Graft Survival in SPK Transplant Among Patients with Diabetes
Luz E. Liriano-Ward, MD, and colleagues at Montefiore Medical Center, Bronx, New York, conducted a retrospective review to examine and compare short-term and long-term...
SGLT-2i Therapy in Kidney Transplant Recipients With Diabetes
In non-transplant patients with chronic kidney disease (CKD) and diabetes, the use of sodium glucose linked transporter inhibitors (SGLT-2i) has been shown to reduce...
Here Are the Biggest Health Industry News Items of 2022 So Far
With each passing day, technology continues to advance. With technological advances comes advances in healthcare. In the past few years alone, there have been...
Promising New Alzheimer’s Drug Reduces Cognitive Decline in Phase 3 Testing
Today, Japanese drug developer Eisai, and Biogen Inc. announced positive topline results from Eisai's large-scale Phase 3 trial which demonstrated that lacanemab, an investigational...
